Home > Insider Trading > Filing (0001062993-22-020119)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1098880	Intelgenx Technologies Corp.	IGXT	Pharmaceutical Preparations (2834)	870638336

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1381866	G Horst Zerbe	714 Main Road Hudson A8 J0P 1H0	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, 0.00001 P.v	Acquisiton	2022-09-30	5,000	$0.13	354,064	No	4	P	Direct
Common Stock, 0.00001 P.v	Acquisiton	2022-09-30	14,000	$0.12	368,064	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, 0.00001 P.v	4,238,680	Indirect	See footnote
Common Stock, 0.00001 P.v	4,238,680	Indirect	See footnote

Footnotes

Shares acquired on the TSX at C$0.175.
Shares acquired on the TSX at C$0.17.
In connection with the acquisition of IntelGenx in 2006, Horst G. Zerbe became our President, Chief Executive Officer and Director and acquired 4,709,643.5 exchangeable shares of our Canadian holding corporation 6544631Canada Inc., a Canadian special purpose corporation which wholly owns IntelGenx Corp. (the "Exchangeable Shares"). The 4,709,643.5 Exchangeable Shares are exchangeable, on a one-for-one basis, into shares of common stock of IntelGenx Technologies Corp. at Horst Zerbe's discretion. On July 28, 2011 Horst Zerbe exchanged 470,964 of the exchangeable shares into shares of Common Stock of IntelGenx Technologies Corp. In January of 2013, Horst Zerbe sold 250,000 of those shares of Common Stock on the open market. In April and August of 2015, Horst Zerbe sold 60,000 and 36,900 of those Shares of Common Stock respectively on the open market.